Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT01780935 · COMPLETED
Trial details
- NCT number
- NCT01780935
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-03
- Primary completion
- 2015-07-09
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.